How close are we to having structure-modifying drugs available?

scientific article published on August 2008

How close are we to having structure-modifying drugs available? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RDC.2008.05.003
P698PubMed publication ID18687283

P2093author name stringDavid J Hunter
Marie-Pierre Hellio Le Graverand-Gastineau
P2860cites workInnervation of the synoviumQ33567300
P433issue3
P304page(s)789-802
P577publication date2008-08-01
P1433published inRheumatic Diseases Clinics of North AmericaQ7320483
P1476titleHow close are we to having structure-modifying drugs available?
P478volume34

Reverse relations

cites work (P2860)
Q36059344Current evidence for osteoarthritis treatments
Q90660123Deep Learning Approach for Evaluating Knee MR Images: Achieving High Diagnostic Performance for Cartilage Lesion Detection
Q37881232Definition of osteoarthritis on MRI: results of a Delphi exercise
Q36931658Emerging drugs for osteoarthritis
Q36244102Evaluation of the effects of a supplementary diet containing chicken comb extract on symptoms and cartilage metabolism in patients with knee osteoarthritis
Q36056916Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects
Q37634998Is osteoarthritis a heterogeneous disease that can be stratified into subsets?
Q30978918Meniscal extrusion or subchondral damage characterize incident accelerated osteoarthritis: Data from the Osteoarthritis Initiative
Q87261618Percutaneous injection of autologous, culture-expanded mesenchymal stem cells into carpometacarpal hand joints: a case series with an untreated comparison group
Q37809746Pharmacologic therapy for osteoarthritis—the era of disease modification
Q37213622The future of osteoarthritis therapeutics: targeted pharmacological therapy

Search more.